Sana Biotechnology Inc
(SANA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160,456 | 176,765 | 163,343 | 194,659 | 188,517 |
| Marketable Securities | 194,950 | 253,298 | 328,507 | 290,143 | 323,861 |
| TOTAL | $369,908 | $444,437 | $500,250 | $494,414 | $523,220 |
| Non-Current Assets | |||||
| PPE Net | 64,260 | 66,917 | 67,349 | 67,846 | 68,693 |
| Investments And Advances | 5,825 | 10,051 | 25,823 | 94,764 | 145,014 |
| Intangibles | 199,822 | 199,822 | 199,822 | 199,822 | 199,822 |
| Other Non-Current Assets | 107,113 | 101,493 | 104,858 | 114,243 | 110,864 |
| TOTAL | $377,020 | $378,283 | $397,852 | $476,675 | $524,393 |
| Total Assets | $746,928 | $822,720 | $898,102 | $971,089 | $1,047,613 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,334 | 2,857 | 3,993 | 3,079 | 4,765 |
| Accrued Expenses | 30,327 | 40,909 | 39,470 | 31,976 | 28,210 |
| Other current liabilities | 57,224 | 55,345 | 59,429 | 51,386 | 50,900 |
| TOTAL | $102,777 | $111,504 | $114,813 | $97,108 | $93,510 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 215,889 | 211,901 | 217,270 | 234,476 | 252,448 |
| TOTAL | $215,889 | $211,901 | $217,270 | $234,476 | $252,448 |
| Total Liabilities | $318,666 | $323,405 | $332,083 | $331,584 | $345,958 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 191,501 | 191,361 | 190,726 | 190,232 | 189,668 |
| Common Shares | 19 | 19 | 19 | 19 | 19 |
| Retained earnings | -1,136,959 | -1,054,836 | -974,393 | -889,273 | -816,808 |
| Other shareholders' equity | -2,139 | -4,327 | -6,414 | -6,347 | -5,172 |
| TOTAL | $428,262 | $499,315 | $566,019 | $639,505 | $701,655 |
| Total Liabilities And Equity | $746,928 | $822,720 | $898,102 | $971,089 | $1,047,613 |